Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1I2 | O75469 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 1/20 | 1.00 |
| ▸ | PGR | P06401 | 1/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | FNTA | P49354 | 1/20 | 0.49 |
| ▸ | FNTB | P49356 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.45 |
| ▸ | SQLE | Q14534 | 4/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2833787 | 1.00 | NR1I2 (1.00) | NR1I2LMNAPGRALDH1A1KMT2A | |
| Lycopene SCHEMBL29401313 | 1.00 | NR1I2 (1.00) | NR1I2LMNAPGRALDH1A1KMT2A | |
| Lycopene SCHEMBL29725051 | 1.00 | NR1I2 (1.00) | NR1I2LMNAPGRALDH1A1KMT2A | |
| Lycopene SCHEMBL4538742 | 1.00 | NR1I2 (1.00) | NR1I2LMNAPGRALDH1A1KMT2A | |
| Lycopene SCHEMBL20158 | 1.00 | NR1I2 (1.00) | NR1I2LMNAPGRALDH1A1KMT2A | |
| Lycopene SCHEMBL30471634 | 1.00 | NR1I2 (1.00) | NR1I2LMNAPGRALDH1A1KMT2A | |
| Lycopene SCHEMBL38650730 | 1.00 | NR1I2 (1.00) | NR1I2LMNAPGRALDH1A1KMT2A | |
| Lycopene SCHEMBL30272252 | 1.00 | NR1I2 (1.00) | NR1I2LMNAPGRALDH1A1KMT2A | |
| Lycopene SCHEMBL21485499 | 1.00 | NR1I2 (1.00) | NR1I2LMNAPGRALDH1A1KMT2A | |
| Lycopene SCHEMBL1423405 | 1.00 | NR1I2 (1.00) | NR1I2LMNAPGRALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101744731-A | Cosmetic of lecithin liposome encapsulated with lycopene | NANJING LUNDI TRADING & INDUST | 2010-06-23 | — | — | CN | claimed |
| CN-118304281-A | Use of lycopene | 河南农业大学 | 2024-07-09 | — | — | CN | disclosed |
| US-11696920-B2 | Intelligent delivery of ingested and absorbed molecules | IMMD SP. ZO.O (PL) | 2023-07-11 | — | — | US | disclosed |
| US-20200261482-A1 | INTELIGENT DELIVERY OF INGESTED AND ABSORBED MOLECULES | IMMD SP. ZO.O (PL) | 2020-08-20 | — | — | US | disclosed |
| EP-3534884-A1 | INTELLIGENT DELIVERY OF INGESTED AND ABSORBED MOLECULES | Immd SP. Zo.o (PL) | 2019-09-11 | — | — | EP | disclosed |
| CN-105638902-B | A method of improving the antioxidative stabilizer of milk | 江南大学 | 2019-04-23 | — | — | CN | disclosed |
| CN-107648307-A | A kind of composition, its preparation method and application | 浙江养生堂天然药物研究所有限公司 | 2018-02-02 | — | — | CN | disclosed |
| CN-105367369-B | A kind of preparation method of the All-cislycopene of stabilization | 南京生矶坊生物工程有限公司 | 2017-06-20 | — | — | CN | disclosed |
| CN-106135470-A | A has the function of health care edible vegetable oil method for preparing | 贵州省玉屏康惠植物油厂 | 2016-11-23 | — | — | CN | disclosed |
| CN-106135462-A | A lycopene vegetable oil method for preparing | 贵州省玉屏康惠植物油厂 | 2016-11-23 | — | — | CN | disclosed |
| WO-2001010204-A1 | NON-MAMMALIAN TRANSGENIC ANIMAL MODEL FOR CELLULAR PROLIFERATIVE DISEASES | TOSK, INC. (US) | 2001-02-15 | — | — | WO | disclosed |
| CN-1272059-A | Carotenoid formulations | HENKEL CORP (US) | 2000-11-01 | — | — | CN | disclosed |
| US-5684238-A | Biosynthesis of zeaxanthin and glycosylated zeaxanthin in genetically engineered hosts | AMOCO CORPORATION (US) | 1997-11-04 | — | — | US | disclosed |
| US-5656472-A | TRANSFORMED HOST ORGANISMS | AMOCO CORPORATION (US) | 1997-08-12 | — | — | US | disclosed |
| US-5545816-A | DNA SEGMENTS ENCODING THE ERWINIA HERBICOLA ENZYMES GERANYLGERANYL PYROPHOSPHATE SYNTHASE AND PHYTOENE SYNTHASE | AMOCO CORPORATION (US) | 1996-08-13 | — | — | US | disclosed |
| US-5530188-A | TRANSFORMATION; MAINTAINING INCREASE IN LYCOPENE CYCLASE PRODUCTION LEADING TO AN INCREASE IN THE AMOUNT OF TOTAL CAROTENOIDS | AMOCO CORPORATION (US) | 1996-06-25 | — | — | US | disclosed |
| US-5530189-A | FOOD COLORING | AMOCO CORPORATION (US) | 1996-06-25 | — | — | US | disclosed |
| EP-0471056-A4 | — | — | 1994-01-12 | — | — | EP | disclosed |
| EP-0471056-A1 | BIOSYNTHESIS OF CAROTENOIDS IN GENETICALLY ENGINEERED HOSTS | AMOCO CORPORATION (US) | 1992-02-19 | — | — | EP | disclosed |
| WO-1991013078-A1 | BIOSYNTHESIS OF CAROTENOIDS IN GENETICALLY ENGINEERED HOSTS | AMOCO CORPORATION (US) | 1991-09-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11696920-B2 | Intelligent delivery of ingested and absorbed molecules | FABP2, FABP1, ELOVL3 | NR1I2 667/4885LMNA 978/4885PGR 2457/4885 |
| US-20200261482-A1 | INTELIGENT DELIVERY OF INGESTED AND ABSORBED MOLECULES | FABP2, FABP1, CPT1A | NR1I2 906/4885LMNA 745/4885PGR 2009/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.